| Active substance |
Dutasteride |
| Also known as |
Not applicable |
| Blood pressure |
Can lead to a modest reduction in blood pressure |
| Chemical name |
Dulaglutide |
| Dosage (medical) |
Generally, 0.75 mg to 1.5 mg once weekly, subcutaneously |
| Dosage (sports) |
Not applicable |
| Effects |
Improves glycemic control in type 2 diabetes |
| Formula |
C2646H4044N704O836S18 |
| Half-life |
Approximately 5 days |
| Hepatotoxicity |
Minimal to no hepatotoxicity reported |
| Lab Test |
May interfere with some blood glucose tests |
| Main action |
Lowers blood sugar levels by enhancing glucose-dependent insulin secretion |
| Side effects |
Nausea, diarrhea, vomiting, abdominal pain, decreased appetite |
| Storage conditions |
Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) |
| Strength |
0.5mg |
| Substance class |
Glucagon-like peptide-1 (GLP-1) receptor agonist |
| Trade name |
Trulicity |
| Use in sports |
Not typically used in sports |
| Water Retention |
No significant effect on water retention |
| Manufacturer |
Johnlee Pharmaceuticals Pvt. Ltd. |
| Packing |
10 tabs/blister |
